Start-up to sell ‘unapproved’ replica Ozempic, upending market
Online weight loss brands Juniper and Pilot will soon begin selling replica Ozempic, defying health warnings from its manufacturer and medical regulators, as Australians face a year with the weight loss drug in vanishingly short supply.
The two brands, which are run by the $560 million Woolworths-backed telehealth start-up Eucalyptus, will have a version of the drug made at two Australian compounding pharmacies in a move that could upend the local market.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Technology
Fetching latest articles